Incentive Spirometry in Non-critically Ill Hospitalized Patients With Acute Respiratory Failure

NCT ID: NCT02873000

Last Updated: 2017-04-18

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2017-04-30
• Study Completion Date: 2017-06-30

Brief Summary

To evaluate the use of Incentive Spirometry in Non-critically Ill Hospitalized Patients With Shortness of Breath.

Detailed Description

In recent years the focus in medicine has shifted towards efficient utilization of resources and improving patient outcomes. Incentive spirometry (IS) is a tool that mimics the natural process of yawning or sighing by allowing the user to take deep breaths in a controlled setting. This is a lung inflating maneuver that has been suggested to decrease the rate of pulmonary complications. The focus of utilization of IS and current studies has been predominantly on the post-operative surgical patient population. The mechanism of pulmonary complications in surgical patients is mixed in etiology possibly related to anesthesia, analgesics, pain and immobility leading to shallow breathing and subsequent atelectasis with concurrent hypoxia and risk of infection. The use of lung expanding maneuvers such as that provided by IS are thought to counteract shallow breathing thereby improving pulmonary outcomes. However, contrary to physiological theory, multiple studies and meta-analysis have failed to demonstrate its efficacy. The results of these studies are in direct conflict with what is expected scientifically.

The authors of this paper set out to find the reason for discordant data in existing literature, and found that there have been multiple methodological limitations associated with existing studies; hence, interpretation and recommendations based on current data should be done with caution. The common denominator in repeated criticisms of existing studies is lack of reporting on patient compliance with IS after it is prescribed. This is a major confounder, in clinical experience IS is often observed sitting dormant at patients' bedside. These observations are in synchrony with criticisms reported in literature and raise serious questions about validity of existing data that should be acknowledged. Despite lack of convincing evidence, IS is routinely prescribed by physicians in hospital medicine. IS is a low cost tool, nevertheless, the increasing frequency of its use is accumulating to a larger proportion of health care costs. This calls for further evaluation with a study of higher methodological quality to address the limitations of prior studies.

The scope of this study is different than that of existing studies in that it will evaluate the utility of IS in general medical patients. The sub-set of patients that are the focus of this study are those admitted with the chief complaint of "shortness of breath." The disease process in the former group leading to shortness of breath includes fluid over-load such as that in congestive heart failure, or an underlying lung process such as pneumonia, COPD, and/or pulmonary embolism. There is a parallel between mechanism of hypoxia in these patients and surgical patients in that these patients too often have pain and take high doses of analgesics, have shallow monotonous breathing and are immobile for long periods of time. From a physiological standpoint sustained maximal inhalation maneuvers may reverse and prevent progression of atelectasis by maintaining airway patency in all patients with shallow breathing of varying etiology not just the surgical sub-set.

In a tertiary center community teaching hospital the effectiveness of IS in general medical wards will be evaluated using a single center randomized clinical trial. The goal is to offer a study that overcomes the limitations of prior studies. Lack of strong evidence based data has led to inconsistencies in practice of physicians leading to higher health care costs. The authors hope to design a study of high methodological quality to assess the effectiveness of IS in medical patients; thereby closing the knowledge gap in evidence based practices that may aid physicians in their decision to utilize IS.

Conditions

Pulmonary Complication; Dyspnea; Pneumonia; COPD; CHF; Atelectasis; PE

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Routine Care Group

Routine Care (R): Standard of care therapy based on admitting diagnosis

Group Type: NO_INTERVENTION

No interventions assigned to this group

Experimental Group

Intervention 1 (E1): addition of incentive spirometry every hour while awake;

There will be a computerized protocol with specific instructions documenting:

1. compliance

2. patient position while using [sitting up vs laying flat in bed]

3. inspiratory volume attained

4. effort, motivation and compliance will subjectively be documented using a visual analogue 0-5 point scale.

Group Type: EXPERIMENTAL

Incentive Spirometry

Intervention Type: BEHAVIORAL

Incentive Spirometer is a tool that allows for deep breathing in a controlled setting while providing the user with visual feedback demonstrating the inspiratory volume of each breath.

Interventions

Incentive Spirometry

Incentive Spirometer is a tool that allows for deep breathing in a controlled setting while providing the user with visual feedback demonstrating the inspiratory volume of each breath.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Patients presenting to the ED with chief complaint of "shortness of breath," admitted to the hospitalist service
• Age >65 yrs of age

Exclusion:

• Patients who can not follow instructions/use IS device
• Cognitive impairment (Dementia/delirium/Developmental delay)
• Heavy sedation
• Inability to take part in deep breathing due to pain or diaphragmatic dysfunction
• Suicide or psych watch
• Patients under isolation
• ICU admission or care within the last 48 hours
• Recent hospitalization 30 days.
• Intubation within the last 60 days
• Routine care group patients that have IS prescribed to them by the admitting MD
• Chronic/Home oxygen dependence

• Minimum Eligible Age: 65 Years
• Maximum Eligible Age: 99 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Jewish Hospital, Cincinnati, Ohio

OTHER

Sponsor Role: lead

Responsible Party

Imran Naqvi

Chief Hospitalist, Associated Program Director

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Imran Naqvi, MD

Role: PRINCIPAL_INVESTIGATOR

Jewish Hospital of Cincinnati

Nasim Motayar, MD

Role: PRINCIPAL_INVESTIGATOR

Jewish Hospital of Cincinnati

Locations

Jewish Hospital of Cincinnati

Cincinnati, Ohio, United States

Countries

United States

Central Contacts

Imran Naqvi, MD

Role: CONTACT

(513) 686-5446

Facility Contacts

Imran Naqvi, MD

Role: primary

Other Identifiers

15-20

Identifier Type: -

Identifier Source: org_study_id